Asked by: Steve Darling (Liberal Democrat - Torbay)
Question to the Ministry of Justice:
To ask the Secretary of State for Justice, whether he plans to reform the family court system to ensure children's best interests are prioritised.
Answered by Alex Davies-Jones - Parliamentary Under-Secretary (Ministry of Justice)
The Children Act 1989 states that the welfare of the child is the court’s paramount consideration when making decisions in relation to a child's upbringing.
This Government is committed to reform of the family court to improve the experience and outcomes for children and families. Central to this is the expansion of the private law Pathfinder model, which amplifies the voice of the child through a Child Impact Report and ensures a higher proportion of children are directly engaged by social workers during proceedings. The model is supporting the court in making safe decisions which prioritise the best interests of the child, without delay.
The Pathfinder pilot was launched in Dorset and North Wales in February 2022 and is now operating across 10 court in England and Wales, which accounts for around a quarter of relevant private law proceedings. Plans for further expansion will be announced in due course.
Asked by: Clive Jones (Liberal Democrat - Wokingham)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what provision the National Cancer Plan will make for orphan drug pathways for patients with rare cancers requiring personalised treatment plans; and how those pathways will differ from existing commissioning arrangements.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
On 4 February 2026, NHS England and the Department published a National Cancer Plan for England. The National Cancer Plan is part of our work to build a National Health Service that is fit for the future and will make England a world-leader for cancer survival.
The orphan drug designation is assessed by the Medicines and Healthcare products Regulatory Agency and is granted at the same time as the marketing authorisation. It provides a period of market exclusivity during which similar competitor medicines cannot enter the United Kingdom market. The orphan drug regulations are designed to support the development of medicines to treat rare diseases including rare cancers.
All new licensed medicines, including orphan medicines, are evaluated by the National Institute for Health and Care Excellence (NICE), which makes recommendations for the NHS on whether they represent a clinically and cost-effective use of NHS resources. NICE aims wherever possible to issue recommendations on new medicines close to the time of licensing, and the NHS in England is legally required to fund medicines recommended by NICE. NICE has a strong track record in recommending orphan medicines for use on the NHS and many thousands of patients with rare diseases have benefitted from access to new medicines as a result.
The Rare Cancers Bill, currently going through the House of Lords, places a duty on the Government to publish a review of the law related to marketing authorisation for rare cancer drugs, for instance orphan drugs for cancer, comparing the UK’s approach to other approaches internationally. Through the National Cancer Plan the Government has committed to full implement of the Rare Cancers Bill to streamline trial pathways and review regulatory barriers that prevent access to promising new treatments.
Asked by: Adam Dance (Liberal Democrat - Yeovil)
Question to the Department for Transport:
To ask the Secretary of State for Transport, if her Department will fund and deliver a public awareness campaign in rural Somerset to promote the updated Highway Code as part of the new Road Safety Strategy.
Answered by Lilian Greenwood - Government Whip, Lord Commissioner of HM Treasury
Following updates to the Highway Code in 2022, the department ran THINK! advertising campaigns nationally to raise awareness of the changes.
Local authorities are responsible for delivering road safety education and have a statutory duty to take steps both to reduce and prevent collisions. THINK! Highway Code campaign resources are available for local authorities to download from the THINK! website and are free to use for educational purposes: https://www.think.gov.uk/campaign/highway-code-changes/.
Via the THINK! campaign, we are also running year-round radio filler adverts across England and Wales encouraging compliance with the Highway Code.
Guidance to improve safety for those walking, cycling and horse riding. We will also continue to promote the changes via THINK! and Department for Transport social media channels, as well as through partner organisations.
In addition to the Highway Code activity, THINK! also runs paid advertising campaigns focused on the priority issues of speed, drink driving and drug driving. The primary audience for these campaigns is young men aged 17-24, who are four times more likely to be killed or seriously injured on the road than drivers aged 25 and over. All THINK! campaigns are run nationally, therefore rural Somerset is included.
As set out in the Road Safety Strategy, more work is needed to continue embedding these changes and overall awareness of the Highway Code. We are considering options in this area, and further details will be shared in due course.
Asked by: Clive Jones (Liberal Democrat - Wokingham)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what statistics he has on the demand for and use of wheelchairs; and how that data informs NHS England’s commissioning of appropriate services.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
Integrated care boards (ICBs) are responsible for the provision and commissioning of local wheelchair services, based on the needs of their local population. NHS England supports ICBs to commission effective, efficient, and personalised wheelchair services and to reduce delays in people receiving timely intervention and wheelchair equipment.
This includes the introduction of personal wheelchair budgets, including through legal rights in 2019, providing a clear framework for ICBs to commission personalised wheelchair services which are outcomes focused and integrated. Personal wheelchair budgets give people greater choice over the wheelchair provided.
NHS England also published a Wheelchair Quality Framework on 9 April 2025, which sets out quality standards and statutory requirements for ICBs. The framework is available at the following link:
https://www.england.nhs.uk/long-read/wheelchair-quality-framework/
Since July 2015, NHS England has collected quarterly data from ICBs on wheelchair provision, including waiting times, to enable targeted action if improvement is required. The latest figures from the Quarter 2 2025/26 National Wheelchair Data Collection showed that 84% of adults and 78% of children received their equipment within 18 weeks. Further information on the National Wheelchair Data Collection is available at the following link:
Local authorities in England have a statutory duty under various legislations, including the Care Act 2014, and the Children and Families Act 2014, to make arrangements for the provision of disability aids and community equipment, to meet the assessed eligible needs of individuals who are resident in their area. Some local authorities deliver this themselves, but a significant number have external contracts for an integrated community equipment service.
NHS England is also responsible for determining allocations of financial resources to ICBs. NHS England’s allocations policy aims to support equal opportunity of access for equal need, alongside NHS England’s duties to reduce health inequalities that are amenable to healthcare.
My Rt Hon. Friend, the Secretary of State for Health and Social Care, has marked 2025/26 as a financial reset year with the publication of Planning Guidance 2025/26. He has been clear that systems must live within their means, exhausting all opportunities to improve productivity, tackle waste, and take decisions on how to prioritise resources to best meet the health needs of their local population.
Asked by: Clive Jones (Liberal Democrat - Wokingham)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether he plans to ensure that NHS organisations and contracted wheelchair service providers are subject to more rigorous, mandatory regulation.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
Integrated care boards (ICBs) are responsible for the provision and commissioning of local wheelchair services, based on the needs of their local population. NHS England supports ICBs to commission effective, efficient, and personalised wheelchair services and to reduce delays in people receiving timely intervention and wheelchair equipment.
This includes publishing a Wheelchair Quality Framework on 9 April 2025, which sets out quality standards and statutory requirements for ICBs. The framework is available at the following link:
https://www.england.nhs.uk/long-read/wheelchair-quality-framework/
NHS England also introduced personal wheelchair budgets, including legal rights in 2019, providing a clear framework for ICBs to commission personalised wheelchair services which are outcomes focused and integrated. Personal wheelchair budgets give people greater choice over the wheelchair provided.
Since July 2015, NHS England has collected quarterly data from ICBs on wheelchair provision, including waiting times, to enable targeted action if improvement is required. The latest figures from the Quarter 2 2025/26 National Wheelchair Data Collection showed that 84% of adults and 78% of children received their equipment within 18 weeks. Further information on the National Wheelchair Data Collection is available at the following link:
The Medium-Term Planning Framework sets a requirement for all providers and ICBs to actively manage long waits for community health services reducing the proportion of all waits over 18 weeks. This will be monitored via the NHS’s usual regional and national assurance processes.
The Community Health Services Situation Report, which will be used to monitor ICB performance against waiting time targets in 2026/27, currently monitors waiting times for both children and young people, and adult waiting times under the ‘Wheelchair, Orthotics, Prosthetics and Equipment’ line. These targets will guide systems to reduce the longest waits, and improvement initiatives to meet these targets may affect waits that are over 18-weeks and 52-weeks.
Asked by: Clive Jones (Liberal Democrat - Wokingham)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether he plans to make the recently developed service specification guidelines for wheelchair services mandatory across England.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
Integrated care boards (ICBs) are responsible for the provision and commissioning of local wheelchair services, based on the needs of their local population. NHS England supports ICBs to commission effective, efficient, and personalised wheelchair services and to reduce delays in people receiving timely intervention and wheelchair equipment.
This includes publishing a Wheelchair Quality Framework on 9 April 2025, which sets out quality standards and statutory requirements for ICBs. The framework is available at the following link:
https://www.england.nhs.uk/long-read/wheelchair-quality-framework/
NHS England also introduced personal wheelchair budgets, including legal rights in 2019, providing a clear framework for ICBs to commission personalised wheelchair services which are outcomes focused and integrated. Personal wheelchair budgets give people greater choice over the wheelchair provided.
Since July 2015, NHS England has collected quarterly data from ICBs on wheelchair provision, including waiting times, to enable targeted action if improvement is required. The latest figures from the Quarter 2 2025/26 National Wheelchair Data Collection showed that 84% of adults and 78% of children received their equipment within 18 weeks. Further information on the National Wheelchair Data Collection is available at the following link:
The Medium-Term Planning Framework sets a requirement for all providers and ICBs to actively manage long waits for community health services reducing the proportion of all waits over 18 weeks. This will be monitored via the NHS’s usual regional and national assurance processes.
The Community Health Services Situation Report, which will be used to monitor ICB performance against waiting time targets in 2026/27, currently monitors waiting times for both children and young people, and adult waiting times under the ‘Wheelchair, Orthotics, Prosthetics and Equipment’ line. These targets will guide systems to reduce the longest waits, and improvement initiatives to meet these targets may affect waits that are over 18-weeks and 52-weeks.
Asked by: Layla Moran (Liberal Democrat - Oxford West and Abingdon)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how lipoedema is classified within NICE guidance and NHS commissioning frameworks; and whether he plans to review the categorisation of lipoedema-related interventions to ensure they reflect clinical need.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
Lipoedema services in England are commissioned locally by integrated care boards (ICBs), which are responsible for assessing the needs of their local populations and determining the most appropriate services to support people with long‑term conditions such as lipoedema.
There is no single national specification for lipoedema services. Instead, ICBs draw on a range of national guidance and best‑practice resources when designing care pathways. These include guidance from the National Institute for Health and Care Excellence (NICE) and best‑practice frameworks produced by bodies such as Wounds UK and the Royal College of General Practitioners. This helps ensure that services are safe, effective, and based on the best available evidence.
Most people with lipoedema are supported through primary and community care services, including assessment by local lymphoedema teams, compression therapy, advice on skin care and movement, and support with self‑management. These services aim to help people manage symptoms and maintain mobility and quality of life.
NICE classifies lipoedema within its interventional procedures guidance on the use of liposuction for chronic lipoedema, reference code HTG618, as a chronic, often painful, and progressive condition characterised by the abnormal, symmetrical accumulation of fat in the legs, hips, buttocks, and sometimes arms. In this guidance, NICE concluded that current evidence on both safety and effectiveness is limited and, therefore, recommends that liposuction should only be undertaken within the context of research or under rigorous governance arrangements. This guidance informs, but does not mandate, local commissioning decisions. NICE will review this guidance once the full results of the ongoing LIPLEG clinical trial are available, and will update its recommendations if new evidence supports doing so.
Asked by: Richard Holden (Conservative - Basildon and Billericay)
Question to the Department for Transport:
To ask the Secretary of State for Transport, what the average grant-supported cost per bus was under each bus procurement scheme in each of the last five years; and what assessment she has made of the potential impact of social value weightings on tendered prices.
Answered by Simon Lightwood - Parliamentary Under-Secretary (Department for Transport)
My Department is not responsible for the procurement of buses and so does not hold this information.
Asked by: Shivani Raja (Conservative - Leicester East)
Question to the HM Treasury:
To ask the Chancellor of the Exchequer, whether her Department has any plans to make (a) Universal Credit, (b) Employment and Support Allowance, and (c) Housing Benefit taxable state benefits.
Answered by James Murray - Chief Secretary to the Treasury
Means-tested benefits that are designed to meet specific costs, such as Universal Credit, income-related Employment and Support Allowance and Pension Credit, are not taxable, and the government has no current plans to alter this.
Asked by: Danny Beales (Labour - Uxbridge and South Ruislip)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to manage conflicts of interest associated with alcohol industry involvement in public health policy.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The Department already has established arrangements in place to manage conflicts of interest for both ministers and civil servants, including where these relate to the alcohol industry.
Ministerial conduct is governed by the Ministerial Code, which sets out requirements on the declaration and handling of ministers’ interests. Civil servants are bound by the Civil Service Code, and by departmental policies that set out how actual, potential, or perceived conflicts of interest must be identified, declared, and managed.
The Department keeps its internal guidance under regular review to ensure it remains aligned with cross-Government standards and supports transparent and accountable decision-making.